Stocktoria
Cosmos Health Inc. COSM
Cosmos Health Inc. (COSM) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $65.3M at a -29.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -3.27 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Wholesale Trade · percentile among 112 companies
Percentile vs other Wholesale Trade companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.002 |
| Retained earnings / assets | -2.034 |
| EBIT / assets | -0.255 |
| Equity / liabilities | 0.392 |
Sector peers · similar-size Wholesale Trade companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| COSM | Cosmos Health Inc. | 5/9 | -7.92 | — | +19.9% |
| ZSTK | ZeroStack Corp. | — | -13.69 | — | -0.5% |
| WGRX | Wellgistics Health, Inc. | 2/9 | — | — | +28.7% |
| NASC | Can B Corp | 1/9 | — | — | — |
| HWH | HWH International Inc. | 3/9 | — | — | — |
| NUS | NU SKIN ENTERPRISES, INC. | 6/9 | 7.36 | 1.6 | -14.3% |
| HLF | HERBALIFE LTD. | 5/9 | 0.63 | 5.7 | +0.9% |
All Wholesale Trade companies →
About Cosmos Health Inc.
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. The company was founded in 2009 and is headquartered in Thessaloniki, Greece.
FAQ
Is COSM financially healthy?
Cosmos Health Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does COSM pay a dividend?
No, Cosmos Health Inc. does not currently pay a dividend.
How profitable is COSM?
In FY2025, Cosmos Health Inc. had a net margin of -29.3% and a return on equity of -103.9%.
What is the analyst price target for COSM?
The average Wall-Street price target for Cosmos Health Inc. is $4.50, about 2072.9% above the recent price, from 1 analysts.
Is COSM a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Cosmos Health Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.